Colin L. Masters

129.6k total citations · 33 hit papers
1.1k papers, 82.7k citations indexed

About

Colin L. Masters is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Colin L. Masters has authored 1.1k papers receiving a total of 82.7k indexed citations (citations by other indexed papers that have themselves been cited), including 685 papers in Physiology, 366 papers in Molecular Biology and 338 papers in Psychiatry and Mental health. Recurrent topics in Colin L. Masters's work include Alzheimer's disease research and treatments (664 papers), Dementia and Cognitive Impairment Research (327 papers) and Prion Diseases and Protein Misfolding (185 papers). Colin L. Masters is often cited by papers focused on Alzheimer's disease research and treatments (664 papers), Dementia and Cognitive Impairment Research (327 papers) and Prion Diseases and Protein Misfolding (185 papers). Colin L. Masters collaborates with scholars based in Australia, United States and Germany. Colin L. Masters's co-authors include Konrad Beyreuther, Ashley I. Bush, Kevin J. Barnham, Gerd Multhaup, Victor L. Villemagne, Ralph N. Martins, Christopher C. Rowe, Roberto Cappai, Robert A. Cherny and G. Simms and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Colin L. Masters

1.1k papers receiving 81.1k citations

Hit Papers

The precursor of Alzheimer's disease amyloid A4 protein r... 1979 2026 1994 2010 1987 1985 2004 2013 1999 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
    1987 3.8k citations Colin L. Masters et al. profile →
  2. Amyloid plaque core protein in Alzheimer disease and Down syndrome.
    1985 3.6k citations Colin L. Masters et al. profile →
  3. Neurodegenerative diseases and oxidative stress
    2004 3.1k citations Kevin J. Barnham, Colin L. Masters et al. profile →
  4. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
    2013 1.6k citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
  5. Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
    1999 1.5k citations Catriona McLean, Ashley I. Bush et al. profile →
  6. Rapid induction of Alzheimer A beta amyloid formation by zinc
    1994 1.3k citations Ashley I. Bush, Colin L. Masters et al. profile →
  7. Alzheimer's disease
    2015 1.3k citations Colin L. Masters, Christopher C. Rowe et al. profile →
  8. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
    2001 1.2k citations Catriona McLean, Kevin J. Barnham et al. profile →
  9. High performance plasma amyloid-β biomarkers for Alzheimer’s disease
    2018 1.1k citations Akinori Nakamura, Victor L. Villemagne et al. profile →
  10. The Amyloid-β Pathway in Alzheimer’s Disease
    2021 1.1k citations Victor L. Villemagne, Paul Aisen et al. profile →
  11. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
    1989 1.0k citations Colin L. Masters et al. profile →
  12. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
    1985 825 citations Colin L. Masters, Ralph N. Martins et al. profile →
  13. Imaging β-amyloid burden in aging and dementia
    2007 813 citations Paul Maruff, Colin L. Masters et al. profile →
  14. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease
    2003 810 citations Ashley I. Bush, Qiao‐Xin Li et al. profile →
  15. Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
    1999 644 citations Colin L. Masters, Ashley I. Bush et al. profile →
  16. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    2011 638 citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
  17. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
    2009 627 citations Ashley I. Bush, Ralph N. Martins et al. profile →
  18. A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
    2017 620 citations Jun Wang, Ben J. Gu et al. profile →
  19.  -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
    2007 616 citations Paul Maruff, Colin L. Masters et al. profile →
  20. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
    1996 596 citations Colin L. Masters et al. profile →
  21. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
    1997 592 citations Colin L. Masters et al. profile →
  22. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
    1990 591 citations Colin L. Masters et al. profile →
  23. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
    2008 586 citations David Ames, Colin L. Masters et al. profile →
  24. Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits
    2001 557 citations Cyril C. Curtain, Colin L. Masters et al. profile →
  25. Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
    1989 519 citations Ralph N. Martins, Colin L. Masters et al. profile →
  26. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
    2005 510 citations Roberto Cappai, Colin L. Masters et al. profile →
  27. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
    2018 464 citations Colin L. Masters et al. profile →
  28. Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
    1979 449 citations Colin L. Masters et al. profile →
  29. Biochemistry of Amyloid  -Protein and Amyloid Deposits in Alzheimer Disease
    2012 444 citations Colin L. Masters et al. profile →
  30. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
    2018 293 citations Victor L. Villemagne, Vincent Doré et al. profile →
  31. Trial of Solanezumab in Preclinical Alzheimer’s Disease
    2023 186 citations Reisa A. Sperling, Michael Donohue et al. profile →
  32. Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
    2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. Alzheimer s & Dementia profile →
  33. Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
    2025 36 citations Colin L. Masters, Jun Wang et al. profile →

Peers

Colin L. Masters
Comparison fields: 5 of 208
  • Physiology 52.1k
  • Molecular Biology 31.1k
  • Psychiatry and Mental health 14.9k
  • Nutrition and Dietetics 10.4k
  • Neurology 10.4k
Replace Rudolph E. Tanzi with:
Rudolph E. Tanzi United States
David M. Holtzman United States
Dennis J. Selkoe United States
John Hardy United Kingdom
Bengt Winblad Sweden
Bradley T. Hyman United States
George Perry United States
Mark P. Mattson United States
Kaj Blennow Sweden
Henrik Zetterberg Sweden
Rudolph E. Tanzi United States View profile →
Citations per field, relative to Colin L. Masters
Colin L. Masters · 1×
Citations per year, relative to Colin L. Masters
Colin L. Masters · 1×

Countries citing papers authored by Colin L. Masters

Since Specialization
Citations

This map shows the geographic impact of Colin L. Masters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin L. Masters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin L. Masters more than expected).

Fields of papers citing papers by Colin L. Masters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin L. Masters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin L. Masters. The network helps show where Colin L. Masters may publish in the future.

Co-authorship network of co-authors of Colin L. Masters

This figure shows the co-authorship network connecting the top 25 collaborators of Colin L. Masters. A scholar is included among the top collaborators of Colin L. Masters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin L. Masters. Colin L. Masters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia
2025 ·JAMA Network Open ·(unknown), (unknown), Yihan Wang, Christopher Fowler, (unknown), Colin L. Masters, James D. Doecke, Benjamin Goudey, Liang Jin, Yijun Pan, Michael W. Weiner, Paul Aisen, Ronald Petersen, Laurel Beckett, Richard J. Perrin, (unknown), Andrew J. Saykin
2
2
Multivariate models using NULISAseq and plasma p‐tau217 for staging Alzheimer's disease
2025 ·Alzheimer s & Dementia ·James D. Doecke, (unknown), Christopher Fowler, Vincent Doré, Nils Boehm, (unknown), (unknown), Azadeh Feizpour, Larry D. Ward, Jürgen Fripp, Colin L. Masters, Christopher C. Rowe, Anthony W. Bannon
0
3
DeepSUVR: Using temporal constraints to improve SUVR and Centiloid quantification
2024 ·Alzheimer s & Dementia ·Pierrick Bourgeat, Jürgen Fripp, (unknown), Timothy Cox, Manu S. Goyal, Duygu Tosun, Pamela LaMontagne, Tammie L.S. Benzinger, (unknown), Victor L. Villemagne, Colin L. Masters, Christopher C. Rowe, Vincent Doré
0
4
Amyloid‐β and monocytes in Alzheimer’s disease
2023 ·Alzheimer s & Dementia ·Xin Huang, Christopher Fowler, Qiao‐Xin Li, Keyla Perez, Yen Ying Lim, (unknown), Rebecca Rumble, Victor L. Villemagne, Christopher C. Rowe, Ralph N. Martins, Paul Maruff, James D. Doecke, Yong Lin, Kevin J. Barnham, Colin L. Masters, Ben J. Gu
1
5
CSF Aβ42 and tau biomarkers in cognitively unimpaired Aβ- middle-aged and older APOE ε4 carriers
2023 ·Neurobiology of Aging ·Yen Ying Lim, Nawaf Yassi, (unknown), Scott Ayton, Rachel F. Buckley, Dhamidhu Eratne, Dennis Velakoulis, Qiao‐Xin Li, Christopher Fowler, Colin L. Masters, Paul Maruff
7
6
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease
2023 ·Journal of Alzheimer s Disease ·Charisse N. Winston, Oliver Langford, (unknown), Rema Raman, Kevin E. Yarasheski, Tim West, (unknown), Michael Donohue, Akinori Nakamura, Kenji Toba, Colin L. Masters, James D. Doecke, Reisa A. Sperling, Paul Aisen, Robert A. Rissman
10
7
How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer’s Disease Research and Clinical Practices?
2023 ·Journal of Alzheimer s Disease ·(unknown), (unknown), Liwei Ma, Yihan Wang, Timothy Cox, Vincent Doré, Colin L. Masters, Benjamin Goudey, Liang Jin, Yijun Pan
1
8
Translating blood biomarkers into clinical practice for Alzheimer's disease: Challenges and perspectives
2023 ·Alzheimer s & Dementia ·Jun Wang, Ming Chen, Colin L. Masters, Yan‐Jiang Wang
9
9
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease
2023 ·Chemical Communications ·Katherine A. Morgan, Michael de Veer, Luke A. Miles, (unknown), Catriona McLean, Colin L. Masters, Kevin J. Barnham, Jonathan M. White, Brett M. Paterson, Paul S. Donnelly
6
10
The performance of AlzoSure® Predict in stratifying the risk to experience a significant cognitive deterioration, due to Alzheimer’s Disease
2023 ·Alzheimer s & Dementia ·(unknown), Simona Piccirella, Leander Van Neste, Christopher Fowler, Colin L. Masters, Jürgen Fripp, James D. Doecke, Daniela Uberti, (unknown)
1
11
Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease
2022 ·Science Advances ·Xian‐Le Bu, Pu‐Yang Sun, Dong‐Yu Fan, Jun Wang, Hao‐Lun Sun, Yuan Cheng, Gui‐Hua Zeng, Dong‐Wan Chen, Huiyun Li, Xu Yi, Ying‐Ying Shen, Luke A. Miles, Paul Maruff, Ben J. Gu, Christopher Fowler, Colin L. Masters, Yan‐Jiang Wang
17
12
Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume
2022 ·Journal of Neurochemistry ·Steve Pedrini, James D. Doecke, Eugene Hone, Penghao Wang, Rohith N. Thota, Ashley I. Bush, Christopher C. Rowe, Vincent Doré, Victor L. Villemagne, David Ames, Stephanie R. Rainey‐Smith, Giuseppe Verdile, Hamid R. Sohrabi, Manfred Raida, Kevin Taddei, Sam Gandy, Colin L. Masters, Pratishtha Chatterjee, Ralph N. Martins
13
13
A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty
2021 ·Frontiers in Digital Health ·Joshua P. White, Adrian Schembri, Chris J. Edgar, Yen Ying Lim, Colin L. Masters, Paul Maruff
5
14
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease
2020 ·Neuroscience Letters ·(unknown), Christopher Fowler, Qiao‐Xin Li, Christopher C. Rowe, Kunal Dhiman, Veer Bala Gupta, Colin L. Masters, James D. Doecke, Ralph N. Martins, Steven Collins, Eleftherios P. Diamandis
5
15
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos
2019 ·Scientific Reports ·Mourad Tayebi, Charles El‐Hage, Pedro Pinczowski, Pam Whiteley, Monique David, Qiao‐Xin Li, Shiji Varghese, (unknown), Umma Habiba, David G. Harman, Liliana Tatarczuch, (unknown), Ian Birchall, (unknown), Larry Walker, Colin L. Masters, Brian A. Summers
2
16
Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults
2018 ·Archives of Clinical Neuropsychology ·Christa Dang, Karra Harrington, Yen Ying Lim, David Ames, Jason Hassenstab, Simon M. Laws, Nawaf Yassi, Martha Hickey, Stephanie R. Rainey‐Smith, Joanne Robertson, Christopher C. Rowe, Hamid R. Sohrabi, Olivier Salvado, Michael Weinborn, Victor L. Villemagne, Colin L. Masters, Paul Maruff
21
17
The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults
2018 ·Intelligence ·Karra Harrington, Christa Dang, Yen Ying Lim, David Ames, Simon M. Laws, Robert H. Pietrzak, Stephanie R. Rainey‐Smith, Joanne Robertson, Christopher C. Rowe, Olivier Salvado, Victor L. Villemagne, Colin L. Masters, Paul Maruff
13
18
Using robust normative data to investigate the neuropsychology of cognitive aging
2016 ·Murdoch Research Repository (Murdoch University) ·Karra Harrington, (unknown), David Ames, Jason Hassenstab, Stephanie R. Rainey‐Smith, Joanne Robertson, Olivier Salvado, Colin L. Masters, Paul Maruff
1
19
Stabilization of Nontoxic Aβ-Oligomers: Insights into the Mechanism of Action of Hydroxyquinolines in Alzheimer's Disease
2015 ·Journal of Neuroscience ·Timothy J. Ryan, Blaine R. Roberts, Gawain McColl, Dominic J. Hare, Philip Doble, Qiao‐Xin Li, Monica Lind, Anne M. Roberts, Haydyn D. T. Mertens, Nigel Kirby, Chi L.L. Pham, Mark G. Hinds, Paul A. Adlard, Kevin J. Barnham, Cyril C. Curtain, Colin L. Masters
62
20
Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study
2014 ·Molecular BioSystems ·Cyril C. Curtain, Nigel Kirby, Haydyn D. T. Mertens, Kevin J. Barnham, Robert Knott, Colin L. Masters, Roberto Cappai, Agata Rekas, Vijaya B. Kenche, Timothy J. Ryan
21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudolph E. Tanzi Breakdown of academic impact, for papers by David M. Holtzman Breakdown of academic impact, for papers by Dennis J. Selkoe Breakdown of academic impact, for papers by John Hardy Breakdown of academic impact, for papers by Bengt Winblad Breakdown of academic impact, for papers by Bradley T. Hyman Breakdown of academic impact, for papers by George Perry Breakdown of academic impact, for papers by Mark P. Mattson Breakdown of academic impact, for papers by Kaj Blennow Breakdown of academic impact, for papers by Henrik Zetterberg
Rankless by CCL
2026